|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT03470532 |
|
Date of registration:
|
09/03/2018 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Comparing Articaine and Mepivacaine Without Palatal Injection in Pain Assessment During Maxillary Teeth Extraction
|
|
Scientific title:
|
Comparing the Effect of 4% Articaine and 2% Mepivacaine Without Palatal Injection in Pain Assessment During Maxillary Teeth Extraction- A Randomized Clinical Trial |
|
Date of first enrolment:
|
February 25, 2017 |
|
Target sample size:
|
60 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT03470532 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: Double (Participant, Investigator).
|
|
Phase:
|
Phase 4
|
|
|
Countries of recruitment
|
|
Malaysia
| | | | | | | |
|
Contacts
|
|
Name:
|
Abdul k Azad, MDS |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Melaka Manipal Medical College,Faculty of Dentistry, Manipal Academy of Higher Education |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients aged 18 years and above
- Patients requiring extraction of maxillary teeth which are grossly decayed, grade I
mobile, root stumps or indicated for therapeutic extractions.
- Healthy patients ( ASA I ) or patients with mild systemic disease with no functional
limitations (ASA II).
- Patients who are not allergic to the drugs used in the study
Exclusion Criteria:
- Patients with periapical infections.
- Patients who are on concurrent treatment with NSAIDs and corticosteroids
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Pain
|
|
Intervention(s)
|
|
Drug: buccal infiltration of 4% Articaine with Epinephrine
|
|
Drug: buccal infiltration of 2% Mepivacaine with Epinephrine
|
|
Primary Outcome(s)
|
|
Measurement of pain intensity
[Time Frame: 10 minutes after the administration of the drug]
|
|
Measurement of pain intensity
[Time Frame: through the extraction procedure]
|
|
Secondary Outcome(s)
|
|
Response rate
[Time Frame: Through the extraction procedure]
|
|
Secondary ID(s)
|
|
MMMC/FOD/AR/B5/E C-2017(24)
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|